Investing.com - Financial Markets Worldwide

ExpreS2ion Biotech Holding AB (EXPRS2)

Stockholm
Currency in SEK
22.65
-0.30(-1.31%)
Closed·
EXPRS2 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
EXPRS2 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
22.0023.65
52 wk Range
0.8237.60
Key Statistics
Edit
Prev. Close
22.95
Open
23.65
Day's Range
22-23.65
52 wk Range
0.82-37.6
Volume
5.24K
Average Volume (3m)
8.14K
1-Year Change
2,386.46%
Book Value / Share
16.01
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EXPRS2 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Buy
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 8
Quickly burning through cash
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

ExpreS2ion Biotech Holding AB Company Profile

ExpreS2ion Biotech Holding AB (publ), a biotechnology company, develops vaccines and biologics products to address critical unmet medical needs in the Nordics and internationally. The company’s lead asset is ES2B-C001, a therapeutic vaccine which is in Phase 1 clinical trials for breast cancer that targets the human epidermal growth factor receptor 2. It is also developing ES2B-I002, a cytomegalovirus vaccine program to treat infectious diseases, as well as vaccines for Nipah virus, Malaria, and influenza. In addition, the company offers a human clinical Phase III-validated technology platform for the development and production of the active material in vaccines under the GlycoX-S2. Further, it out licenses its ExpreS2 platform to research institutes and pharmaceutical companies; and sells ExpreS2 test kits and reagents for research purposes or diagnostic applications. The company has collaboration agreement with University of Oxford for the development of vaccine for malaria. ExpreS2ion Biotech Holding AB (publ) was incorporated in 2015 is based in Helsingborg, Sweden.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
20
Market
Sweden

Compare EXPRS2 to Peers and Sector

Metrics to compare
EXPRS2
Peers
Sector
Relationship
P/E Ratio
−1.3x−11.1x−0.6x
PEG Ratio
−0.03−0.220.00
Price/Book
1.4x7.9x2.6x
Price / LTM Sales
5.8x49.3x3.3x
Upside (Analyst Target)
-11.7%39.1%
Fair Value Upside
Unlock6.6%5.4%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 0.00

Earnings

Latest Release
Aug 21, 2025
EPS / Forecast
-3.77 / --
Revenue / Forecast
3.42M / --
EPS Revisions
a
a
Unlock
Last 90 days

EXPRS2 Income Statement

FAQ

What Stock Exchange Does ExpreS2ion Biotech Trade On?

ExpreS2ion Biotech is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for ExpreS2ion Biotech?

The stock symbol for ExpreS2ion Biotech is "EXPRS2."

What Is the ExpreS2ion Biotech Market Cap?

As of today, ExpreS2ion Biotech market cap is 61.81M.

What Is ExpreS2ion Biotech's Earnings Per Share (TTM)?

The ExpreS2ion Biotech EPS (TTM) is -19.85.

When Is the Next ExpreS2ion Biotech Earnings Date?

ExpreS2ion Biotech will release its next earnings report on 12 Nov 2025.

From a Technical Analysis Perspective, Is EXPRS2 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has ExpreS2ion Biotech Stock Split?

ExpreS2ion Biotech has split 4 times.

How Many Employees Does ExpreS2ion Biotech Have?

ExpreS2ion Biotech has 20 employees.

What is the current trading status of ExpreS2ion Biotech (EXPRS2)?

As of 29 Aug 2025, ExpreS2ion Biotech (EXPRS2) is trading at a price of 22.65, with a previous close of 22.95. The stock has fluctuated within a day range of 22.00 to 23.65, while its 52-week range spans from 0.82 to 37.60.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.